×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
IQVIA Innovation Theater: Pre-Approval Access - Strategies for Providing Investigational Product to Patients Beyond Clinical Trials
Session Chair(s)
IQVIA
United States
This session on Pre-Approval Access (PAA) will address key considerations and challenges for provision of investigational products to patients outside of clinical trials, and before these therapies are approved by regulators. We will focus on key decisions and success factors for organizations to consider when developing their company’s philosophy on this type of access. We will also highlight pragmatic decisions that play into the development of efficient Pre-Approval Access programs.
Speaker(s)
Speaker
Barbara Isquith Arone, MS
IQVIA, United States
Vice President, Evidence Generation for Medical Affairs
Speaker
Ana Tediosi
WEP Clinical, United Kingdom
Head of Expanded Access Strategy
Have an account?